Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help

Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Thoracic cancer Clinical Trials

Protocol Number Title
2008NTCG101
COG ANBL00B1 "Neuroblastoma Biology Studies"
2009NTLS011
Tobacco-related Biomarkers in Head and Neck Squamous Cell Carcinoma; Tobacco-Related Biomarkers for Risk Assessment and Prognosis in the Development and Treatment of Head and Neck Squamous Cell Carcinoma; Tobacco carcinogens as markers of exposure, carcinogenesis and risk in oral cancer.
2011NTLS081
Evaluating the Effectiveness of Reduced Nicotine Cigarettes, part of "Evaluating New Nicotine Standards for Cigarettes"
2011NTLS154
Benzo[a]pyrene Metabolism: Phenotyping and Genotyping Study 4: Deuterated Phenanthrene and NNK Cigarettes
2014IS087
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of GS-5806 in Hematopoietic Cell Transplant (HCT) Recipients with Respiratory Syncytial Virus (RSV) infection of the Upper Respiratory Tract.
2015CG094
Molecular Analysis for Therapy Choice (MATCH)
2015CG151
ADVL1414 - A PHASE 1 STUDY OF SELINEXOR (KPT-330, IND #125052), A SELECTIVE XPO1 INHIBITOR, IN RECURRENT AND REFRACTORY PEDIATRIC SOLID TUMORS, INCLUDING CNS TUMORS
2015CG155
COG ADVL1522 - A Phase 2 Study of IMGN901 (Lorvotuzumab Mertansine; IND# 126953, NSC# 783609) in Children with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) and Synovial Sarcoma
2015IS103
Phase 2, Parallel - Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non‐Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor
2015IS111
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
2015IS145
An Open-label, Randomized Phase 3 Efficacy Study of ASP8273 vs Erlotinib or Gefitinib in First-line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer Tumors with EGFR Activating Mutations
2015LS095
Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women with Advanced Non-Small Cell Lung Cancer
2015NTLS048
Adaptive Interventions for Smoking Cessation in Lung Cancer Screening Programs
2015NTLS120
Masonic Cancer Center Thoracic Translational Working Group Lung Cancer and Pulmonary Nodule Biorepository
2016IS013
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer
2016IS069
A Phase 1/2, Open-Label, Dose-Escalation/Dose-Expansion, Safety and Tolerability Study of INCB057643 in Subjects with Advanced Malignancies
2016IS112
METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
2016NTLS145
ASSESSING THE EFFECT OF GLUCOBRASSICIN-RICH BRUSSELS SPROUTS ON THE METABOLISM OF DEUTERATED PHENANTHRENE: DEVELOPING FOOD-BASED CHEMOPREVENTION OF TOBACCO-RELATED LUNG CANCER
2016UC011
A Phase IB/II study of nivolumab in combination with ALT-803 in patients with pretreated, advanced or metastatic non-small cell lung cancer
EAY131-Z1C
EAY131-Z1C: MATCH Treatment Subprotocol Z1C: Phase II Study of Palbociclib (PD-0332991) in Patients with Tumors with CDK4 or CDK6 Amplification and Rb Protein Expression by IHC

20 trials displayed